» Articles » PMID: 39358547

From Computational Models of the Splicing Code to Regulatory Mechanisms and Therapeutic Implications

Overview
Journal Nat Rev Genet
Specialty Genetics
Date 2024 Oct 2
PMID 39358547
Authors
Affiliations
Soon will be listed here.
Abstract

Since the discovery of RNA splicing and its role in gene expression, researchers have sought a set of rules, an algorithm or a computational model that could predict the splice isoforms, and their frequencies, produced from any transcribed gene in a specific cellular context. Over the past 30 years, these models have evolved from simple position weight matrices to deep-learning models capable of integrating sequence data across vast genomic distances. Most recently, new model architectures are moving the field closer to context-specific alternative splicing predictions, and advances in sequencing technologies are expanding the type of data that can be used to inform and interpret such models. Together, these developments are driving improved understanding of splicing regulatory mechanisms and emerging applications of the splicing code to the rational design of RNA- and splicing-based therapeutics.

Citing Articles

Systematic deletion of symmetrical exons reveals new therapeutic targets for exon skipping antisense oligonucleotides.

Pena-Rasgado C, Rodriguez-Manriquez E, Dundr M, Bridges R, Hastings M, Michaels W NAR Mol Med. 2024; 1(4):ugae017.

PMID: 39582793 PMC: 11579696. DOI: 10.1093/narmme/ugae017.

References
1.
Denti M, Viero G, Provenzani A, Quattrone A, Macchi P . mRNA fate: Life and death of the mRNA in the cytoplasm. RNA Biol. 2013; 10(3):360-6. PMC: 3672278. DOI: 10.4161/rna.23770. View

2.
Li Y, van de Geijn B, Raj A, Knowles D, Petti A, Golan D . RNA splicing is a primary link between genetic variation and disease. Science. 2016; 352(6285):600-4. PMC: 5182069. DOI: 10.1126/science.aad9417. View

3.
Nikom D, Zheng S . Alternative splicing in neurodegenerative disease and the promise of RNA therapies. Nat Rev Neurosci. 2023; 24(8):457-473. DOI: 10.1038/s41583-023-00717-6. View

4.
Bradley R, Anczukow O . RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023; 23(3):135-155. PMC: 10132032. DOI: 10.1038/s41568-022-00541-7. View

5.
Ule J, Blencowe B . Alternative Splicing Regulatory Networks: Functions, Mechanisms, and Evolution. Mol Cell. 2019; 76(2):329-345. DOI: 10.1016/j.molcel.2019.09.017. View